1. WHO Determination and Current Situation
On May 17, 2026, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), after having consulted the States Parties where the event is occurring, determined that the Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations (2005). While the outbreak was deemed serious enough to require urgent international coordination, WHO clarified that it does not currently meet the threshold for a pandemic emergency.
2. Latest Outbreak Data in DRC and Uganda (as of May 19, 2026)
As of May 19, 2026, the outbreak situation has continued to evolve. According to statements from national health authorities, WHO, and the Africa Centres for Disease Control and Prevention (Africa CDC), the latest figures are as follows:
Democratic Republic of the Congo (DRC)
-Suspected cases: 513 reported
-Suspected deaths: 131 reported
-Laboratory confirmed cases: 30
The outbreak remains concentrated in Ituri Province but has now also spread to several health zones in neighboring North Kivu Province.
Uganda
-Laboratory confirmed cases: 2 (unchanged from earlier reports)
-Confirmed deaths: 1
Both confirmed cases were identified in Kampala among individuals traveling from the DRC, with no apparent epidemiological link between them.
International Agency Summaries
-World Health Organization (WHO): On May 19, Dr. Tedros reported that the outbreak has now recorded more than 500 suspected cases and 130 suspected deaths from Ebola across the two countries.
-Africa CDC: On the same day, Africa CDC reported a combined total of 395 suspected cases and 106 related deaths for the DRC and Uganda together.
This outbreak marks the DRC’s 18th Ebola outbreak since 1976, and its second outbreak caused by the Bundibugyo virus. The significant increase in suspected cases and deaths compared to earlier reports reflects ongoing community transmission and enhanced surveillance.
3. Understanding Ebola: The Deadliest Filovirus
Virus Classification – Three Highly Pathogenic Subtypes
Ebola virus belongs to the Filoviridae family and genus Orthoebolavirus. It was first identified in 1976 near the Ebola River in what is now the DRC and is classified as a Biosafety Level 4 (BSL 4) pathogen – one of the most deadly viruses known to humankind.
Six orthoebolavirus species have been identified, of which three are most deadly:
-Zaire ebolavirus: The most virulent (50–90% case fatality rate), responsible for many major historical outbreaks.
-Sudan ebolavirus: Approximately 50% case fatality rate, highly transmissible.
-Bundibugyo ebolavirus: The cause of the current outbreak. First identified in 2007, it has a moderate case fatality rate, with delayed hemorrhagic symptoms and a subtle early presentation, making it easily missed.
Virus Characteristics – Stable and Easily Spread
The virus is filamentous, approximately 80 nm in diameter and up to 1000 nm in length. It is stable at room temperature, inactivated at 60°C after 30 minutes, and can be quickly destroyed by ultraviolet light or common disinfectants. The virus primarily attacks the immune system and destroys vascular walls and organ tissues, leading to multiorgan failure.
4. How Ebola Spreads – Key Routes to Watch
Natural Reservoir – Fruit Bats as “Silent Carriers”
Fruit bats of the Pteropodidae family are the natural reservoir hosts. They do not become ill themselves but can transmit the virus to humans or non human primates (chimpanzees, gorillas, etc.) through their bodily fluids or excreta.
Human to Human Transmission – Direct Contact Is the Core Route
Human infection occurs mainly through direct contact with:
-The blood, vomit, feces, sweat, breast milk, or other bodily fluids of infected or deceased individuals.
-Clothing, bedding, medical equipment, or other items contaminated with the virus.
Healthcare workers and those handling burial practices are at high risk if proper protection is not used.
Incubation Period – 2–21 Days, No Transmission During Incubation
The incubation period ranges from 2 to 21 days (average 5–10 days). Infected individuals are not contagious during the incubation period – transmission begins only after symptoms appear. This provides a critical window for early isolation and containment.
5. Symptoms – Easily Misdiagnosed in Early Stages
Ebola disease progresses in three stages. The Bundibugyo strain has a more subtle early presentation:
-Early stage (Days 1–3): Sudden high fever (≥38.5°C), fatigue, muscle pain, headache, sore throat – closely resembling influenza or malaria, easily misdiagnosed.
-Middle stage (Days 4–7): Vomiting, diarrhea, abdominal pain, rash, liver and kidney dysfunction.
-Late stage (after Day 7): Internal and external bleeding (nosebleeds, gum bleeding, hematemesis, bloody stool), confusion, somnolence, coma, and finally multiorgan failure leading to death.
Critical note: With the Bundibugyo strain, hemorrhagic symptoms appear late. Some patients may never develop visible bleeding, presenting only with persistent high fever and diarrhea – requiring a high index of suspicion.
6. Laboratory Detection – The Key to Early Control
Ebola virus is highly contagious. The core detection methods include:
Nucleic acid testing (Fluorescence PCR): The gold standard for early diagnosis. It can detect the virus as early as 1–3 days after symptom onset, targeting two core genes (NP/GP) of the virus with high sensitivity and specificity.
Antigen detection : A rapid screening method. Positive antigen results can confirm the diagnosis, suitable for batch testing during outbreak peaks.
7. Macro & Micro-Test’s Accurate Ebola Detection
Fluorescence PCR Nucleic Acid Detection Kit
This kit enables qualitative detection of Ebola virus nucleic acid in serum or plasma samples from patients with suspected infection, providing critical technical support for clinical diagnosis. In the face of the high case fatality rate of Ebola hemorrhagic fever, this kit serves as a core laboratory confirmation tool for global public health systems and medical institutions.
In Depth Tracking – Whole Genome Sequencing Solution
By obtaining the full length genomic sequence of the Ebola virus, this solution can:
-Identify viral lineage and phylogenetic classification.
-Track viral mutation and evolutionary trajectories.
-Trace the source and transmission pathways of the virus.
-Provide a scientific basis for formulating outbreak prevention and control strategies.
-Assess trends in viral pathogenicity, enabling continuous optimization of outbreak response.
8. Related Kits
Post time: May-20-2026